yingweiwo

IACS-9571

Alias: IACS-9571 IACS 9571 IACS9571 IACS 009571-001-4
Cat No.:V22368 Purity: ≥98%
IACS-9571 is a novel, potent and selective TRIM24 and BRPF1 inhibitorwithIC50value of 8 nM for TRIM24, and Kds of 31 nM and 14 nM for TRIM24 and BRPF1, respectively.
IACS-9571
IACS-9571 Chemical Structure CAS No.: 1800477-30-8
Product category: Epigenetic Reader Domain
This product is for research use only, not for human use. We do not sell to patients.
Size Price
5mg
10mg
25mg
50mg
100mg
Other Sizes

Other Forms of IACS-9571:

  • IACS-9571 hydrochloride (ASIS-P040 hydrochloride)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description
IACS-9571 is a novel, potent and selective TRIM24 and BRPF1 inhibitor with IC50 value of 8 nM for TRIM24, and Kds of 31 nM and 14 nM for TRIM24 and BRPF1, respectively. With the low nanomolar affinities for TRIM24 and BRPF1 (ITC Kd = 31 nM and 14 nM, respectively), excellent cellular potency (EC50 = 50 nM) and favorable pharmacokinetic properties (F = 29%), IACS-9571 is a high-quality chemical probe for the evaluation of TRIM24 and/or BRPF1 bromodomain function in vitro and in vivo.
IACS-9571 is a potent and selective small molecule inhibitor of the bromodomain-containing proteins TRIM24 and BRPF1. It has a molecular formula of C32H42N4O8S and a molecular weight of 642.77 g/mol. IACS-9571 inhibits TRIM24 with an IC50 of 8 nM and binds to BRPF1 with a Kd of 14 nM. TRIM24 is a chromatin reader that recognizes acetylated histones and is involved in transcriptional regulation, while BRPF1 is a scaffold protein in histone acetyltransferase complexes. IACS-9571 is used as a research tool to study epigenetic regulation and as a potential anticancer agent.
Biological Activity I Assay Protocols (From Reference)
Targets
The primary molecular targets of IACS-9571 are the bromodomains of TRIM24 and BRPF1. TRIM24 contains a PHD-bromodomain tandem reader that binds to acetylated histone H3 and regulates gene expression. BRPF1 contains a bromodomain that recognizes acetylated histones and is part of the MOZ/MORF histone acetyltransferase complexes. IACS-9571 binds to the acetyl-lysine binding site of these bromodomains, preventing their interaction with chromatin. This inhibits the transcriptional programs driven by TRIM24 and BRPF1, leading to antiproliferative effects in cancer cells.
ln Vitro
IACS-9571 has an EC50 of 50 nM, demonstrating good cellular potency. Strong activity is shown by IACS-9571 (1 μM) against a panel of 32 bromodomains. IACS-9571 is a TRIM24/BRPF1 dual inhibitor that is selective (Kd = 1.3/2.1 nM), with selectivities of 9 and 21 fold for BRPF2 and BRPF3, respectively. IACS-9571 is more than 7,700 times more selective than BRD4(1, 2) in comparison to TRIM24 [1] and does not interact with the BET subfamily of bromodomains.
In vitro activity of IACS-9571 has been characterized using bromodomain binding assays and cancer cell proliferation assays. In AlphaScreen or TR-FRET assays, IACS-9571 inhibits TRIM24-histone peptide interaction with an IC50 of 8 nM. In cancer cell lines including leukemia, breast, and prostate cancer, IACS-9571 inhibits proliferation with IC50 values in the low micromolar range. It also induces apoptosis and cell cycle arrest.
ln Vivo
In vivo activity of IACS-9571 has been evaluated in mouse xenograft models. Administration of IACS-9571 inhibits tumor growth in TRIM24-dependent cancer models. Tumor tissue analysis shows decreased expression of TRIM24 target genes. Pharmacokinetic studies indicate that IACS-9571 has moderate oral bioavailability and a plasma half-life suitable for daily dosing. No overt toxicity has been observed at efficacious doses.
Enzyme Assay
In vitro bromodomain binding assays for IACS-9571 use recombinant TRIM24 or BRPF1 bromodomains and a fluorescently labeled acetylated histone peptide. IACS-9571 is serially diluted and incubated with the bromodomain and peptide. Binding is measured by fluorescence polarization or TR-FRET. IC50 or Kd values are determined from dose-response curves.
Cell Assay
In vitro cell experiments with IACS-9571 use cancer cell lines such as MV4-11 (leukemia), MCF-7 (breast), or LNCaP (prostate). Cells are cultured in standard media and treated with IACS-9571 at concentrations ranging from 0.01 to 10 µM for 24-72 hours. Proliferation is assessed by MTT or CellTiter-Glo assays. Apoptosis is measured by caspase-3/7 activity or annexin V staining. Target gene expression is measured by RT-PCR.
Animal Protocol
In vivo animal experiments with IACS-9571 use athymic nude mice bearing subcutaneous xenografts. IACS-9571 is formulated in DMSO/PEG300/Tween-80/saline or 0.5% methylcellulose and administered by oral gavage or intraperitoneal injection at doses of 10-50 mg/kg daily. Tumor volume is measured twice weekly. At study termination, tumors are harvested for Western blotting and immunohistochemistry. All procedures follow institutional animal care guidelines.
References

[1]. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor. J Med Chem. 2016 Feb 25;59(4):1440-54.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C32H42N4O8S
Molecular Weight
642.7629
Exact Mass
642.272
CAS #
1800477-30-8
Related CAS #
IACS-9571 hydrochloride;2319611-93-1
PubChem CID
91808039
Appearance
Typically exists as solid at room temperature
LogP
4.5
tPSA
128
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
10
Rotatable Bond Count
16
Heavy Atom Count
45
Complexity
1030
Defined Atom Stereocenter Count
0
SMILES
CCCOC1=CC(=CC(=C1)OC2=CC3=C(C=C2NS(=O)(=O)C4=CC(=C(C=C4)OC)OC)N(C(=O)N3C)C)OCCCCN(C)C
InChi Key
HYQBRUSSCIAOOD-UHFFFAOYSA-N
InChi Code
InChI=1S/C32H42N4O8S/c1-8-14-42-22-16-23(43-15-10-9-13-34(2)3)18-24(17-22)44-30-21-28-27(35(4)32(37)36(28)5)20-26(30)33-45(38,39)25-11-12-29(40-6)31(19-25)41-7/h11-12,16-21,33H,8-10,13-15H2,1-7H3
Chemical Name
N-(6-(3-(4-(dimethylamino)butoxy)-5-propoxyphenoxy)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-3,4-dimethoxybenzenesulfonamide
Synonyms
IACS-9571 IACS 9571 IACS9571 IACS 009571-001-4
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.5558 mL 7.7790 mL 15.5579 mL
5 mM 0.3112 mL 1.5558 mL 3.1116 mL
10 mM 0.1556 mL 0.7779 mL 1.5558 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us